Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 135 of the 140 references it cites were found in a registry or an index.

Sarcoidosis

Valeyre, Dominique, Prasse, Antje, Nunes, Hilario, Uzunhan, Yurdagul, Brillet, Pierre-Yves, Müller-Quernheim, Joachim·2014·The Lancet

Abstract

Sarcoidosis is a systemic disease of unknown cause that is characterised by the formation of immune granulomas in various organs, mainly the lungs and the lymphatic system. Studies show that sarcoidosis might be the result of an exaggerated granulomatous reaction after exposure to unidentified antigens in individuals who are genetically susceptible. Several new insights have been made, particularly with regards to the diagnosis and care of some important manifestations of sarcoidosis. The indications for endobronchial ultrasound in diagnosis and for PET in the assessment of inflammatory activity are now better specified. Recognition of unexplained persistent disabling symptoms, fatigue, small-fibre neurological impairment, cognitive failure, and changes to health state and quality of life, has improved. Mortality in patients with sarcoidosis is higher than that of the general population, mainly due to pulmonary fibrosis. Predicted advances for the future are finding the cause of sarcoidosis, and the elucidation of relevant biomarkers, reliable endpoints, and new efficient treatments, particularly in patients with refractory sarcoidosis, lung fibrosis, and those with persistent disabling symptoms.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(13)60680-7

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 140 references

Research works printed but not linked: 3

  1. Judson, 2006, The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 23, 51
  2. Bradley, 2008, Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society, Thorax, 63, v1
  3. Baughman, 2004, Leflunomide for chronic sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 21, 43

Cited by

See all 1,087

Metadata

Authors
Valeyre, D., Prasse, A., Nunes, H., Uzunhan, Y., Brillet, P.-Y., & Müller-Quernheim, J.
Affiliations
  • Université Sorbonne Paris Nord (FR)
  • University Medical Center Freiburg (DE)
  • Sorbonne Paris Cité (FR)
Corresponding author
Valeyre, Dominique
Venue
The Lancet
Publisher
Elsevier BV
Published
2014-03
Volume
383
Issue
9923
Pages
1155-1167
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4211032738
Cited by
1,087
References
140
Citations by year
2026: 60 · 2025: 76 · 2024: 78 · 2023: 95 · 2022: 96 · 2021: 112 · 2020: 101 · 2019: 120 · 2018: 99 · 2017: 74 · 2016: 78 · 2015: 76 · 2014: 21
FWCI
6.47
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoidosis and Beryllium Toxicity Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Medical Imaging and Pathology Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Keywords
sarcoidosis, granuloma, pulmonary sarcoidosis, lymph node involvement, endobronchial ultrasound, positron emission tomography, inflammatory activity assessment, refractory sarcoidosis, pulmonary fibrosis, small fiber neuropathy, fatigue, cognitive impairment, quality of life, mortality, biomarkers, pathogenesis
MeSH terms
Diagnosis, Differential, Diagnostic Imaging, Exercise Test, Granuloma, HLA-D Antigens, Humans, Inflammation, Long-Term Care, Prognosis, Sarcoidosis, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sarcoidosis. https://app.cochat.ai/papers/10.1016/s0140-6736(13)60680-7
The paper
Valeyre, D., Prasse, A., Nunes, H., Uzunhan, Y., Brillet, P.-Y., & Müller-Quernheim, J. (2014). Sarcoidosis. The Lancet. https://doi.org/10.1016/s0140-6736(13)60680-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.